Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone for Hazardous Drinking in HIV-Infected Women
NCT01245647Phase 2Completed
- Sponsor
- University of Florida
- Start
- Nov 2010
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of naltrexone in alcohol use disorder (AUD), sponsored by University of Florida. Primary endpoint: Number of Drinks Per Week at 4 months. Started Nov 2010; status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT01245647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01245647.